Clinical Trials Logo

Human Papillomavirus Infections clinical trials

View clinical trials related to Human Papillomavirus Infections.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02009800 Completed - Clinical trials for Human Papillomavirus Infections

ICI-VPH: Impact of HPV Immunisation Schedules Against HPV

ICI-VPH
Start date: November 2013
Phase: Phase 3
Study type: Interventional

This randomised clinical trial aims to determine whether an immunization schedule comprising two doses of Gardasil administered six months apart is non-inferior to a schedule comprising three doses administered at 0, 6 and 60 months for the prevention of HPV-16 and HPV-18 infections that persist for at least six months, up to ten years after the initial vaccination. The study hypothesis is that the two-dose schedule would offer similar protection as that of a three-dose schedule against persistent HPV-16/18 infections.

NCT ID: NCT01717443 Completed - Clinical trials for Human Papillomavirus Infections

Genital HPV Infections Before and After Renal Transplantation

Start date: February 2012
Phase: N/A
Study type: Observational

The purpose of this study is to examine the prevalence, incidence and genotype of anogenital HPV infections in women before and after renal transplantation. With this information the investigators can determine the value of vaccination in patients waiting for renal transplantation in the future.

NCT ID: NCT01077856 Completed - Clinical trials for Human Papillomavirus Infections

GARDASILâ„¢ Vaccine Impact in Population Study (V501-033)

VIP
Start date: May 29, 2007
Phase:
Study type: Observational

This study will assess the impact of GARDASILâ„¢ human papillomavirus (HPV) vaccine in the general female population by utilizing nationwide registry databases in the participating Nordic countries.